ACP-105

Mild SARM with reported cognitive and lean-tissue benefits.

Typical dose range: 5–15 mg

Frequency: Daily

Route: Oral

Half-life: ~12 hours

Evidence level: Pre-clinical

Overview

Lower potency than RAD-140 or LGD with milder suppression. Limited human data.